Fish Douglas N, Ohlinger Martin J
Department of Clinical Pharmacy, School of Pharmacy, University of Colorado Health Sciences Center, Campus Box C-238, 4200 East Ninth Avenue, Denver, CO 80262, USA.
Crit Care Clin. 2006 Apr;22(2):291-311, vii. doi: 10.1016/j.ccc.2006.02.006.
Antimicrobial resistance in the ICU is characterized by increasing overall resistance rates among gram-negative and gram-positive pathogens and increased frequency of multidrug-resistant organisms. In addition to basic principles of appropriate drug selection for empiric and definitive therapy, other specific strategies that may decrease problems of resistance through improved use of antimicrobials include appropriate application of pharmacokinetic and pharmacodynamic principles to antimicrobial use, aggressive dosing of antimicrobials, use of broad-spectrum and combination antimicrobial therapy for initial treatment, decreased duration of antimicrobial therapy, hospital formulary-based antimicrobial restrictions, use of antimicrobial protocols and guidelines, programs for restriction of target antimicrobials, scheduled antimicrobial rotation, and use of antimicrobial management programs. Combinations of various approaches may offer the best potential for effectively intervening in and reducing the spread of resistant pathogens in critically ill patients.
重症监护病房(ICU)中的抗菌药物耐药性表现为革兰氏阴性菌和革兰氏阳性菌病原体的总体耐药率不断上升,以及多重耐药菌的出现频率增加。除了经验性和确定性治疗中合理选择药物的基本原则外,通过改进抗菌药物使用来减少耐药问题的其他具体策略包括:将药代动力学和药效学原理合理应用于抗菌药物使用、积极给予抗菌药物剂量、使用广谱和联合抗菌治疗进行初始治疗、缩短抗菌治疗疗程、基于医院处方集的抗菌药物限制、使用抗菌药物方案和指南、限制目标抗菌药物的计划、定期进行抗菌药物轮换,以及使用抗菌药物管理方案。各种方法的组合可能为有效干预和减少重症患者中耐药病原体的传播提供最佳潜力。